Get the Full Story, Without the Noise.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Memorial Day
Republican Party
Artificial Intelligence
Cannes Film Festival
Social Media
Education
Taxes
US Politics
Senate
Donald Trump
Democratic Party
Natural Disasters
Published • loading... • Updated

The Liéges-based biotech Imcyse in liquidation after disappointing clinical results

Summary by La Libre
Liege-based biotechnology company Imcyse, specializing in immunotherapies, will be liquidated following disappointing clinical results, reports L'Echo on Thursday. The company plans to lay off its entire workforce, totaling around 40 people.

1 Articles

All
Left
Center
1
Right
La LibreLa Libre
Center

The Liéges-based biotech Imcyse in liquidation after disappointing clinical results

Liege-based biotechnology company Imcyse, specializing in immunotherapies, will be liquidated following disappointing clinical results, reports L'Echo on Thursday. The company plans to lay off its entire workforce, totaling around 40 people.

·Brussels, Belgium
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

La Libre broke the news in Brussels, Belgium on Thursday, June 20, 2024.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Liège

Liège

News
For You
SearchBlindspotLocal